Acquisition of relenza to support a public health emergency response to pandemic
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSO100200600016I
- Awardee
-
Glaxosmithkline Holdings (Americas) Inc. UEI QQH9KHXNCG81
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- DHHSORDCVB0606 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $82,861,551.35
- Award type
- Single award
- Funding agency
- Immediate Office of the Secretary Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Health and Human Services to GlaxoSmithKline Holdings (Americas) Inc. for the acquisition of Relenza to support a public health emergency response to a pandemic. The single-award IDC has a total ceiling value of $82,861,551.35 and a period of performance running from the award date of July 14, 2006 through the ultimate completion date of September 1, 2010. This contract was not set aside for any specific socioeconomic category.
The primary purpose of this IDC is to enable the government to rapidly acquire the antiviral medication Relenza in the event of a public health emergency, such as an influenza pandemic. While the specific details of any task orders placed under this contract are not provided, the broad scope indicates this IDC serves as a pre-positioned vehicle to facilitate the efficient procurement and delivery of this critical medical countermeasure when needed to support emergency response efforts led by the Department of Health and Human Services.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,303,449 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $4,208,250 | |
| Original award | $16,833,000 |
Quick answers
Who was awarded contract HHSO100200600016I?
HHSO100200600016I was awarded to Glaxosmithkline Holdings (Americas) Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 14, 2006.
How much is contract HHSO100200600016I worth?
HHSO100200600016I's own ceiling is $82,861,551.
Which agency awarded contract HHSO100200600016I?
Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) awarded HHSO100200600016I, with funding from Immediate Office of the Secretary (Department of Health and Human Services).
Who can order from contract HHSO100200600016I?
HHSO100200600016I is a single award indefinite delivery contract.
Was contract HHSO100200600016I competed?
The extent of competition for HHSO100200600016I was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV